|Mr. Kristian Villumsen||Pres & CEO||16.1M||N/A||1970|
|Mr. Anders Lonning-Skovgaard||Exec. VP & CFO||8M||N/A||1972|
|Mr. Allan Rasmussen||Exec. VP of Global Operations||7.3M||N/A||1967|
|Mr. Nicolai Buhl Andersen||Exec. VP of Innovation||6.6M||N/A||1969|
|Mr. Paul Marcun||Exec. VP of Growth||8.3M||N/A||1967|
|Mr. Rasmus Hannemann Møller||Sr. VP of Wound & Skin Care||N/A||N/A||N/A|
|Mr. Thomas Barfod||Sr. Controller & Employees Representative Director||450k||N/A||1970|
|Ellen Bjurgert||VP of Investor Relations||N/A||N/A||N/A|
|Dennis Kaysen||Director of Corp. Communications||N/A||N/A||N/A|
|Dorthe Ronnau||Sr. VP of People & Culture||N/A||N/A||1966|
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Coloplast A/S’s ISS governance QualityScore as of 1 October 2022 is 4. The pillar scores are Audit: 1; Board: 5; Shareholder rights: 9; Compensation: 2.